Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy (Q24646477)

30 June 2019

Cold agglutinin disease

1 reference

Creative Commons Attribution 2.0 Generic

inferred from title

author

Geir Erland Tjønnfjord

series ordinal

object named as

Geir E Tjønnfjord

0 references

Sigbjørn Berentsen

series ordinal

object named as

Sigbjørn Berentsen

0 references

author name string

Klaus Beiske

series ordinal

0 references

language of work or name

English

0 references

publication date

October 2007

0 references

1 October 2007

1 reference

30 June 2019

1 reference

30 June 2019

0 references

0 references

361-70

0 references

1 reference

Europe PubMed Central

Autoimmune haemolysis: an 18-year study of 865 cases referred to a regional transfusion centre

30 June 2019

copyrighted

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

7 April 2017

Cold agglutinin disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Autoimmune hemolytic anemia

7 April 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

7 April 2017

Cold hemolytic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Dangerous small B-cell clones.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

The role of complement in the therapeutic activity of rituximab in a murine B lymphoma model homing in lymph nodes

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Clinical characteristics and outcome of immunoglobulin M-related disorders.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Immune-mediated hemolytic anemia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Human monoclonal macroglobulins with antibody activity

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

IgG Fc receptor polymorphisms in human disease: implications for intravenous immunoglobulin therapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Acute phase haemolysis in chronic cold agglutinin disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Rituximab (anti-CD20) therapy of B-cell lymphomas: direct complement killing is superior to cellular effector mechanisms

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Molecular characterization of cold agglutinins

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Naturally occurring anti-i/I cold agglutinins may be encoded by different VH3 genes as well as the VH4.21 gene segment

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Red cell destruction in cold agglutinin disease.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Activation of complement by cold agglutinins

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

The cold hemagglutinin disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Cryopathic gangrene with an IgM lambda cryoprecipitating cold agglutinin

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Physical properties of the red cell agglutinins in acquired hemolytic anemia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Blood clonal B-cell excess in patients with monoclonal gammopathy of undetermined significance (MGUS): association with malignant transformation.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Protein Abnormalities in the Cold Haemagglutinin Syndrome

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Exclusive occurrence of K chains in isolated cold haemagglutinins.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

The biological effects of IgM hexamer formation.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Translocation (8;22) in cold agglutinin disease associated with B-cell lymphoma

19 June 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701445392

Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701445392

Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701445392

Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701445392

Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701445392

2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701445392

Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701445392

Caractéristiques des anémies hémolytiques auto-immunes de l’adulte : analyse rétrospective d’une série de 83 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330701445392

Primary chronic cold agglutinin disease: a population based clinical study of 86 patients.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Type-specific cold auto-antibodies as a cause of acquired hemolytic anemia and hemolytic transfusion reactions: biologic test with bovine red cells

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

Etiologic aspects of cold agglutinin disease: evidence for cytogenetically defined clones of lymphoid cells and the demonstration that an anti-Pr cold autoantibody is derived from a chromosomally aberrant B cell clone.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409172

[Chronic cold agglutinin disease]

28 November 2018

1 reference

12 December 2020

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene

1 reference

12 December 2020

Alpha-interferon for severe cold agglutinin disease

1 reference

12 December 2020

B-cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins)

1 reference

12 December 2020

The effects of interferon-alpha2a on concentrations of immunoglobulins, complement and lymphocytes in patients with multiple sclerosis

1 reference

12 December 2020

Production of IgM hexamers by normal and autoimmune B cells: implications for the physiologic role of hexameric IgM

1 reference

12 December 2020

Rituximab in autoimmune cytopenias: for which patients?

1 reference

12 December 2020

Cold agglutinin hemolysis responding to fludarabine therapy

1 reference

12 December 2020

Electrophoretic studies on sera containing high-titre cold haemagglutinins: identification of the antibody as the cause of an abnormal gamma 1 peak

1 reference

12 December 2020

No response to cladribine in five patients with chronic cold agglutinin disease

1 reference

12 December 2020

The syndrome of high-titre cold haemagglutination; a survey and a case report

1 reference

12 December 2020

Thermodynamics of the Cold Agglutinin Reaction

1 reference

12 December 2020

Cold agglutinin activity is common among human monoclonal IgM Rh system antibodies using the V4-34 heavy chain variable gene segment

1 reference

12 December 2020

[Rituximab in cold agglutinin disease]

1 reference

12 December 2020

Chronic hemolytic anemia due to a monoclonal IgG cold agglutinin with anti-Pr specificity

1 reference

12 December 2020

Images in clinical medicine. Seasonal hemolysis due to cold-agglutinin syndrome

1 reference

12 December 2020

Fludarabine in Waldenstrom's macroglobulinemia

1 reference

12 December 2020

IMMUNOCHEMICAL PROPERTIES OF COLD HAEMAGGLUTININS

1 reference

12 December 2020

Trisomy 3q11-q29 is recurrently observed in B-cell non-Hodgkin's lymphomas associated with cold agglutinin syndrome

1 reference

12 December 2020

Immunopathologic and clinical features of hemolytic anemia due to cold agglutinins

1 reference

12 December 2020

CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59

1 reference

12 December 2020

The Pattern of Erythrocyte Destruction in Haemolytic Anaemia, as Studied with Radioactive Chromium

1 reference

12 December 2020

Effect of interferon-alpha on CD20 antigen expression of B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Complement and Complement Components in Acquired Hemolytic Anemia with High Titer Cold Antibodies

1 reference

12 December 2020

Rituxan in the treatment of cold agglutinin disease

1 reference

12 December 2020

Failure of interferon-alpha-2b therapy in chronic cold agglutinin disease

1 reference

12 December 2020

The variability of hemolysis in the cold agglutinin syndrome

1 reference

12 December 2020

Paradoxical haemolysis in a patient with cold agglutinin disease

1 reference

12 December 2020

Chronic cold agglutinin disease of the "idiopathic" type is a premalignant or low-grade malignant lymphoproliferative disease

1 reference

12 December 2020

Clinical immunology of chronic cold agglutinin disease

1 reference

12 December 2020

Hemolysis by complement and cold-reacting antibodies: Time and temperature requirements

1 reference

12 December 2020

The Syndrome of High-Titre Cold Hemagglutination

1 reference

https://api.crossref.org/works/10.1080%2F10245330701445392

7 January 2021